Christopher P.

Babson College, recognized globally for its leadership in entrepreneurship education, enhances student entrepreneurs' knowledge and tools for financial decision-making through its MBA programs.

• Teach a specialized course, 'Finance for New Ventures', enriching Babson's graduate programs.
• Empower student entrepreneurs with practical insights into evaluating financing options and aligning financial strategies with business objectives.
• Designed and implemented a curriculum focused on real-world application, fostering analytical and strategic thinking among students.
• Facilitator of vibrant classroom discussions, encouraging a culture of innovation and critical financial analysis.

A rapidly growing genomics tools company revolutionizing biomedical research with its proprietary STARmap technology and advancing the development of the Pyxa suite for intricate cellular mapping in disease research.

• Instrumental in steering Stellaromics Inc. towards transformative financial milestones in preparation for a lucrative IPO.
• Spearheaded the evolution of the company's finance function, adding the people and infrastructure needed to drive key financial insights.
• Charged with overseeing all financial operations, ensuring compliance and strategic financial planning to support the company's research and development efforts.

An innovative startup utilizing AI to revolutionize clinical research workforce efficiency, thereby resolving the pervasive issue of delayed trials in the healthcare sector.

• Leverage extensive experience to advise on strategic directions, contributing to Stack's mission of aligning technology with clinical trial workforce optimization.
• Provide critical insights into AI-driven solutions, enhancing trial efficiency and reducing time to market for essential healthcare innovations.
• Instrumental in curating strategic initiatives that bolster Stack's positioning in the healthcare industry, emphasizing the importance of an efficient clinical trial workforce.

Reveal Pharmaceuticals addresses a significant gap in MRI diagnostics by developing safe, gadolinium-free contrast agents, enhancing patient safety and environmental health.

• Oversaw comprehensive financial management, positioning Reveal for pivotal Phase 2 clinical studies of its innovative MRI contrast agent, RVP-001.
• Guided financial strategy and funding acquisition, including securing critical NIH grants, to advance the development of gadolinium-free contrast agents.
• Spearheaded efforts for financial transparency and compliance in the highly regulated pharmaceutical landscape.
• Facilitated cross-functional team alignment, ensuring synchronized effort towards achieving clinical milestones and financial viability.

Harvard Business School is among the world's most trusted sources of management education and thought leadership.

• Authored 20+ case studies and tools on entrepreneurial finance, business models, and growth strategy.
• Mentored student founders on investor communications, GTM planning, and early-stage fundraising.

A leading provider of corporate governance training and consultancy, serving a global clientele including multinational corporations and financial institutions.

• Founded and strategically grew a consultancy focused on addressing critical needs in corporate governance across global markets.
• Designed and launched tailored training programs that significantly improved governance practices among client organizations.
• Spearheaded high-impact consulting projects that resulted in enhanced board effectiveness and governance frameworks.
• Drove business expansion into key international markets, establishing the firm as a preferred partner for corporate governance solutions.

A private equity firm providing innovative investment solutions that address structural inefficiencies within the industry.

• Played a pivotal role in establishing the U.S. footprint of the firm, broadening its reach and access to investment opportunities.
• Developed and implemented investment strategies that capitalized on market inefficiencies, delivering superior returns to investors.
• Cultivated strategic relationships with stakeholders, enhancing the firm’s market position and investment capacity.